Hologic (HOLX) Shares are Down -0.74%

Hologic (HOLX) has risen sharply, recording gains of 6.41% in the past 4 weeks. However, the stock has corrected -0.74% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 5.32% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 2.38% and the 50-Day Moving Average is 8.04%. Hologic (NASDAQ:HOLX): On Fridays trading session , Opening price of the stock was $38.85 with an intraday high of $38.94. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $38.43. However, the stock managed to close at $38.68, a loss of 0.44% for the day. On the previous day, the stock had closed at $38.85. The total traded volume of the day was 1,448,530 shares.


The company Insiders own 0.84% of Hologic shares according to the proxy statements. Institutional Investors own 92.14% of Hologic shares. Also, Evercore ISI Group upgrades its rating on Hologic (NASDAQ:HOLX). Analysts at the Evercore ISI Group have a current rating of Buy on the shares. The shares were previously rated Hold. The rating by the firm was issued on July 28, 2016.

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. The Companys business units are focused on diagnostics, breast health, GYN surgical and skeletal health. The Companys diagnostics products include Aptima family of assays, its ThinPrep system, the Rapid Fetal Fibronectin Test and its Procleix blood screening assays. The Aptima family of assays is used to detect the infectious microorganisms that cause the common sexually transmitted diseases, chlamydia and gonorrhea, certain high-risk strains of human papillomavirus (HPV), and Trichomonas vaginalis, the parasite that causes trichomoniasis. The Companys GYN surgical products include its NovaSure Endometrial Ablation System and its MyoSure Hysteroscopic Tissue Removal System. The skeletal health products include dual-energy X-ray bone densitometry systems, an ultrasound-based osteoporosis assessment product, and its Fluoroscan mini C-arm imaging products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.